No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: A pilot study

The results of our pilot study suggested that anti-GM1 and anti-GAD antibodies are rare and they did not associate with therapy-resistance and other parameters in JME syndrome.